The demise of a planned randomised controlled trial in an urban Aboriginal medical service.

PubWeight™: 3.41‹?› | Rank: Top 1%

🔗 View Article (PMID 11999260)

Published in Med J Aust on March 18, 2002

Authors

Beverly M Sibthorpe1, Ross S Bailie, Maggie A Brady, Sandra A Ball, Polly Sumner-Dodd, Wayne D Hall

Author Affiliations

1: National Centre for Epidemiology and Population Health, Australian National University, Canberra, ACT. beverly.sibthorpe@anu.edu.au

Articles by these authors

Opioid overdose deaths can occur in patients with naltrexone implants. Med J Aust (2007) 4.86

Exploring conditions under which it may be ethical to offer incentives to encourage drug-using women to use long-acting forms of contraception. Addiction (2012) 3.99

Assessment of Swedish snus for tobacco harm reduction: an epidemiological modelling study. Lancet (2007) 3.97

Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. Lancet (2013) 3.65

The long-term effectiveness of brief interventions for unsafe alcohol consumption: a 10-year follow-up. Addiction (2002) 2.61

Healthy country, healthy people: the relationship between Indigenous health status and "caring for country". Med J Aust (2009) 2.48

The global epidemiology and contribution of cannabis use and dependence to the global burden of disease: results from the GBD 2010 study. PLoS One (2013) 2.17

Should the health community promote smokeless tobacco (snus) as a harm reduction measure? PLoS Med (2007) 2.10

Patterns of antipsychotic medication use in Australia 2002-2007. Aust N Z J Psychiatry (2010) 1.86

The persistence of the association between adolescent cannabis use and common mental disorders into young adulthood. Addiction (2012) 1.83

The enhancement use of neuropharmaceuticals: more scepticism and caution needed. Addiction (2010) 1.58

From "our world" to the "real world": Exploring the views and behaviour of policy-influential Australian public health researchers. Soc Sci Med (2011) 1.55

Per capita alcohol consumption in Australia: will the real trend please step forward? Med J Aust (2010) 1.54

Multiple genetic tests for susceptibility to smoking do not outperform simple family history. Addiction (2009) 1.51

Under what conditions is it ethical to offer incentives to encourage drug-using women to use long-acting forms of contraception? Addiction (2012) 1.49

Sociodemographic correlates of antidepressant utilisation in Australia. Med J Aust (2009) 1.47

The demand for surgery: an analysis of referrals from Australian general practitioners. ANZ J Surg (2004) 1.47

Ambient biomass smoke and cardio-respiratory hospital admissions in Darwin, Australia. BMC Public Health (2007) 1.45

Mortality among cocaine users: a systematic review of cohort studies. Drug Alcohol Depend (2010) 1.40

UK classification of cannabis: is a change needed and why? Lancet (2007) 1.38

The global epidemiology and burden of opioid dependence: results from the global burden of disease 2010 study. Addiction (2014) 1.35

Evaluation of a multi-component community tobacco intervention in three remote Australian Aboriginal communities. Aust N Z J Public Health (2006) 1.28

Smart drugs "as common as coffee": media hype about neuroenhancement. PLoS One (2011) 1.27

Delivery of preventive health services to Indigenous adults: response to a systems-oriented primary care quality improvement intervention. Med J Aust (2007) 1.25

Making systematic reviews more useful for policy-makers. Bull World Health Organ (2005) 1.23

Substance use and the adolescent brain: a toxic combination? J Psychopharmacol (2007) 1.23

A longitudinal study of the association of adolescent polydrug use, alcohol use and high school non-completion. Addiction (2015) 1.16

Specialist outreach to isolated and disadvantaged communities: a population-based study. Lancet (2006) 1.12

Delivery of maternal health care in Indigenous primary care services: baseline data for an ongoing quality improvement initiative. BMC Pregnancy Childbirth (2011) 1.08

Reaching "an audience that you would never dream of speaking to": influential public health researchers' views on the role of news media in influencing policy and public understanding. J Health Commun (2013) 1.08

Effect of health promotion and fluoride varnish on dental caries among Australian Aboriginal children: results from a community-randomized controlled trial. Community Dent Oral Epidemiol (2011) 1.07

The association between four citation metrics and peer rankings of research influence of Australian researchers in six fields of public health. PLoS One (2011) 1.07

'Occasional' and 'social' smokers: potential target groups for smoking cessation campaigns? Aust N Z J Public Health (2006) 1.05

Galvanizers, guides, champions, and shields: the many ways that policymakers use public health researchers. Milbank Q (2011) 1.04

Aboriginal health workers and diabetes care in remote community health centres: a mixed method analysis. Med J Aust (2006) 1.03

Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: patient characteristics and patterns and predictors of treatment retention. Addiction (2009) 1.01

Cigarette tax and public health: what are the implications of financially stressed smokers for the effects of price increases on smoking prevalence? Addiction (2010) 1.01

The effect of a reduction in heroin supply on fatal and non-fatal drug overdoses in New South Wales, Australia. Med J Aust (2005) 1.00

Why do they do it? A pilot study towards understanding participant motivation and experience in a large genetic epidemiological study of endometriosis. Community Genet (2007) 0.99

Impulse control disorders in patients with Parkinson's disease receiving dopamine replacement therapy: evidence and implications for the addictions field. Addiction (2010) 0.97

Assessing the quality of maternal health care in Indigenous primary care services. Med J Aust (2010) 0.97

Identifying trustworthy experts: how do policymakers find and assess public health researchers worth consulting or collaborating with? PLoS One (2012) 0.97

Improvement in rheumatic fever and rheumatic heart disease management and prevention using a health centre-based continuous quality improvement approach. BMC Health Serv Res (2013) 0.96

Is there evidence of 'hardening' among Australian smokers between 1997 and 2007? Analyses of the Australian National Surveys of Mental Health and Well-Being. Aust N Z J Psychiatry (2010) 0.96

Assessing the wisdom of funding DrinkWise. Med J Aust (2006) 0.95

Public views on food addiction and obesity: implications for policy and treatment. PLoS One (2013) 0.95

Tailoring access to high cost, genetically targeted drugs. Med J Aust (2005) 0.94

Vegetation fires, particulate air pollution and asthma: a panel study in the Australian monsoon tropics. Int J Environ Health Res (2006) 0.94

Should burden of disease estimates include cannabis use as a risk factor for psychosis? PLoS Med (2009) 0.94

What are the major drivers of prevalent disability burden in young Australians? Med J Aust (2011) 0.92

Measuring emotional and social wellbeing in Aboriginal and Torres Strait Islander populations: an analysis of a Negative Life Events Scale. Int J Equity Health (2007) 0.92

Making new choices about antidepressants in Australia: the long view 1975-2002. Med J Aust (2004) 0.92

Stores Healthy Options Project in Remote Indigenous Communities (SHOP@RIC): a protocol of a randomised trial promoting healthy food and beverage purchases through price discounts and in-store nutrition education. BMC Public Health (2013) 0.91

Alcohol policy reform in Australia: what can we learn from the evidence? Med J Aust (2010) 0.91

Should Australia lift its ban on low nitrosamine smokeless tobacco products? Med J Aust (2008) 0.91

Liver function test abnormalities in users of aqueous kava extracts. J Toxicol Clin Toxicol (2003) 0.91

Development and preliminary validation of the 'Caring for Country' questionnaire: measurement of an Indigenous Australian health determinant. Int J Equity Health (2008) 0.90

Increasing cancer mortality among opioid-dependent persons in Australia: a new public health challenge for a disadvantaged population. Aust N Z J Public Health (2011) 0.89

Using pharmacogenetics and pharmacogenomics in the treatment of psychiatric disorders: some ethical and economic considerations. J Mol Med (Berl) (2003) 0.88

The epidemiology of cannabis use and cannabis-related harm in Australia 1993-2007. Addiction (2010) 0.87

The "alcopops" tax: heading in the right direction. Med J Aust (2009) 0.86

A study of the use of free nicotine patches by Indigenous people. Aust N Z J Public Health (2003) 0.86

Is the socioeconomic gap in childhood exposure to secondhand smoke widening or narrowing? Tob Control (2012) 0.86

Alcohol sales data are essential for good public policies towards alcohol. Med J Aust (2008) 0.85

The Global Burden of Disease projects: what have we learned about illicit drug use and dependence and their contribution to the global burden of disease? Drug Alcohol Rev (2013) 0.85

Television and delivery of health promotion programs to remote Aboriginal communities. Health Promot J Austr (2005) 0.85

Polysubstance use in cannabis users referred for treatment: drug use profiles, psychiatric comorbidity and cannabis-related beliefs. Front Psychiatry (2013) 0.85

Is the "alcopops" tax working? Probably yes but there is a bigger picture. Med J Aust (2011) 0.85

The neurobiology of overeating. Treating overweight individuals should make use of neuroscience research, but not at the expense of population approaches to diet and lifestyle. EMBO Rep (2012) 0.85

Dental self-care and dietary characteristics of remote-living Indigenous children. Rural Remote Health (2006) 0.83

Smokeless tobacco use in Australia. Drug Alcohol Rev (2009) 0.83

Depression and psychological distress in tobacco smokers and people with cannabis dependence in the National Survey of Mental Health and Wellbeing. Med J Aust (2011) 0.83

Would vaccination against nicotine be a cost-effective way to prevent smoking uptake in adolescents? Addiction (2012) 0.83

Utilization of anti-Parkinson drugs in Australia: 1995-2009. Pharmacoepidemiol Drug Saf (2011) 0.82

Exploring the characteristics of the research workforce in Aboriginal and Torres Strait Islander health. Aust N Z J Public Health (2008) 0.82

Anticipating the use of life extension technologies. EMBO Rep (2010) 0.82

Five genetic variants associated with prostate cancer. N Engl J Med (2008) 0.81

Academic doping or Viagra for the brain? The history of recreational drug use and pharmacological enhancement can provide insight into these uses of neuropharmaceuticals. EMBO Rep (2011) 0.81

The demise of a planned randomised controlled trial in an urban Aboriginal medical service. Med J Aust (2002) 0.81

Why we need tobacco sales data for good tobacco control. Med J Aust (2010) 0.81

Early identification and preventive care for elevated cardiovascular disease risk within a remote Australian Aboriginal primary health care service. BMC Health Serv Res (2011) 0.81

Preventing growth faltering among Australian Indigenous children: implications for policy and practice. Med J Aust (2008) 0.80

Prescribing databases can be used to monitor trends in opioid analgesic prescribing in Australia. Aust N Z J Public Health (2013) 0.80

Genetic screening for susceptibility to depression: can we and should we? Aust N Z J Psychiatry (2004) 0.80

The adverse effects of cannabinoids: implications for use of medical marijuana. CMAJ (2008) 0.79

How should we regulate smokeless tobacco products and e-cigarettes? Med J Aust (2012) 0.78

The effects of the market withdrawal of temazepam gel capsules on benzodiazepine injecting in Sydney, Australia. Drug Alcohol Rev (2008) 0.77

Impact of income management on store sales in the Northern Territory. Med J Aust (2010) 0.77

Psychiatric drug prescribing in elderly Australians: time for action. Aust N Z J Psychiatry (2011) 0.77

Community perceptions on the significant extension of life: an exploratory study among urban adults in Brisbane, Australia. Soc Sci Med (2008) 0.77

Minimising the misuse of oxycodone and other pharmaceutical opioids in Australia. Med J Aust (2011) 0.77

The role of remote community stores in reducing the harm resulting from tobacco to Aboriginal people. Drug Alcohol Rev (2006) 0.77

Error and bias in the evaluation of prescription opioid misuse: should the FDA regulate clinical assessment tools? Pain Med (2013) 0.77

Response to Hser et al. (2014): The necessity for more and better data on the global epidemiology of opioid dependence. Addiction (2014) 0.76

National health workforce in discrete Indigenous communities. Aust N Z J Public Health (2004) 0.76

Explaining the convergence of male and female smoking prevalence in Australia. Addiction (2008) 0.76